Filing Details
- Accession Number:
- 0001209191-19-046807
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-20 16:30:50
- Reporting Period:
- 2019-08-19
- Accepted Time:
- 2019-08-20 16:30:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-19 | 4,250 | $131.89 | 35,803 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-19 | 4,250 | $186.37 | 31,553 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-19 | 3,592 | $91.05 | 35,145 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-19 | 1,796 | $186.37 | 33,349 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-19 | 1,796 | $186.41 | 31,553 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-19 | 4,659 | $86.52 | 36,212 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-19 | 2,329 | $186.41 | 33,883 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-08-19 | 2,330 | $186.37 | 31,553 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2019-08-19 | 4,250 | $0.00 | 4,250 | $131.89 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2019-08-19 | 3,592 | $0.00 | 3,592 | $91.05 |
| Common Stock | Common Stock (right to buy) | Acquisiton | 2019-08-19 | 4,659 | $0.00 | 4,659 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-07-20 | No | 4 | M | Direct | |
| 3,592 | 2026-02-01 | No | 4 | M | Direct | |
| 13,980 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Fully vested.
- The option vests in 16 quarterly installments from 02/02/2016.
- The option vests in 16 quarterly installments from 02/03/2017.
Billionaire Hedge Funds
